A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
Actym Therapeutics, Inc.
Day One Biopharmaceuticals, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
Elevation Oncology
Seagen Inc.
Sotio Biotech Inc.
Merck Sharp & Dohme LLC
Pfizer
Fusion Pharmaceuticals Inc.
Genmab
MacroGenics
National Institutes of Health Clinical Center (CC)
Tocagen Inc.
Seagen Inc.
CureOne
Celldex Therapeutics